27 September 2023
27 September 2023
Edwards Lifesciences has come forward as the cardiovascular device company at the centre of the European Commission investigation of potential antitrust violations.
The FDA-cleared system for traditional laparoscopy assistance has been used in weight loss procedures in the US.
The test combines five epigenetic biomarkers with the PSA score to predict prostate cancer presence or absence.
The system helps improve patient outcomes by enhancing otolaryngologists' capabilities with advanced functionality.
The procedure is part of a clinical study supported by the European Innovation Council, investigating the therapy’s safety and effectiveness.
The Eversense systems were inserted into more than 165 adult subjects in four US centres.
The study will assess the usability of the PressureSafe device to detect pressure injuries in people with darker skin tones.
The company plans to initiate recruitment of patients for the trial in the first half of next year.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Generative AI can improve personalized healthcare by collecting data from patients via wearable devices, which can provide continuous, real-time data that can complement traditional data sources such as imaging, patient records, and more. It can also enhance existing imaging techniques by generating high-quality images of organs using data from low-resolution images (such as ultrasounds). However, the collection and use of patient healthcare data through AI medical products could conflict with regulations around the globe.
Give your business an edge with our leading industry insights.
